CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity

Area of Science:

• Immunology
• Oncology
• Cell Therapy

Background:

• Chimeric Antigen Receptor (CAR)-T cell therapy is a revolutionary cancer treatment, highly effective against hematologic malignancies.
• Significant hurdles impede the widespread application of CAR-T cell therapy in solid tumors.

Purpose of the Study:

• To review the evolution of CAR-T technologies and address challenges in solid tumor treatment.
• To explore innovative CAR-T strategies, including CAR-Treg, CAR-NK, and CAR-M cells.
• To examine the emerging role of CAR-based therapies in autoimmune disorders.

Main Methods:

• Comprehensive review of existing literature on CAR-T cell therapy development.
• Analysis of preclinical and clinical studies investigating CAR-T applications in solid tumors and autoimmune diseases.
• Discussion of novel CAR constructs and combination therapeutic approaches.

Main Results:

• CAR-T cell therapy faces unique challenges in the tumor microenvironment of solid tumors.
• Innovations such as engineered CAR-T cells, combination therapies, and alternative CAR-cell types (CAR-Treg, CAR-NK, CAR-M) offer potential solutions.
• CAR-based therapies are demonstrating efficacy in preclinical and clinical studies for autoimmune conditions.

Conclusions:

• CAR technologies hold transformative potential beyond oncology, particularly in treating autoimmune diseases.
• Continued research into overcoming solid tumor barriers and refining CAR-cell designs is crucial for broader clinical success.
• The versatility of CAR-based cell therapies suggests a significant impact on future medical treatments.